Exonhit Therapeutics S.A.
Records under this name other than the patents Exonhit Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Exonhit Therapeutics S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,168,631 | 3-(4-Fluorophenyl)-3-Hydroxy-2-Amino-PROPIONIC Acid Amides and Related Compounds Having Analgesic Activity Formerly held In force · High confidence | In force | High confidence | |
| US 9,479,826 | Method and System for Wireless Data Communication Formerly held In force · High confidence | In force | High confidence | |
| US 9,902,710 | Substituted 6, 7-Dialkoxy-3-Isoquinoline Derivatives as Inhibitors of Phosphodiesterase 10 (PDE 10A) Formerly held In force · High confidence | In force | High confidence | |
| US 8,835,463 | Compounds Having Analgesic And/Or Immunostimulant Activity Term ended Term ended Sep 8, 2026 · High confidence | Term ended | Term ended Sep 8, 2026 | High confidence |
| US 8,772,316 | Substituted 6,7-Dialkoxy-3-Isoquinolinol Derivatives as Inhibitors of Phosphodiesterase 10 (PDE10A) Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,431,599 | 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity Term ended Term ended Jan 25, 2026 · USPTO record | Term ended | Term ended Jan 25, 2026 | USPTO record |
| US 8,927,589 | 3-ARYL-3-Hydroxy-2-Amino-PROPIONIC Acid Amides, 3-Heteroaryl-3-Hydroxy-2-Aminopropionic Acid Amides and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity Term ended Term ended Jan 25, 2026 · Medium confidence | Term ended | Term ended Jan 25, 2026 | Medium confidence |
| US 9,278,943 | Methods of Using as Analgesics 1-Benzyl-1-Hydroxy-2, 3-Diamino-PROPYL Amines, 3-Benzyl-3-Hydroxy-2-Amino-PROPIONIC Acid Amides and Related Compounds Term ended Term ended Jan 25, 2026 · High confidence | Term ended | Term ended Jan 25, 2026 | High confidence |
| US 9,828,349 | 1-ARYL-1-Hydroxy-2,3-Diamino-PROPYL Amines, 1-Heteroaryl-1-Hydroxy-2,3-Diamino-PROPYL Amines and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity Term ended Term ended Jan 25, 2026 · High confidence | Term ended | Term ended Jan 25, 2026 | High confidence |
| US 8,513,288 | 1-ARYL-1-Hydroxy-2,3-Diamino-PROPYL Amines, 1-Heteroaryl-1-Hydroxy-2,3-Diamino-PROPYL Amines and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity Lapsed on the fee record Ended Aug 20, 2025 · High confidence | Lapsed on the fee record | Ended Aug 20, 2025 | High confidence |